Stocks
Amneal Pharmaceuticals, Inc.AMRX
NASDAQHealthcarePharmaceuticals$11.83-2.35%
Price as of · delayed, not real-time
A global pharmaceutical company specializing in the development, manufacturing, and distribution of generic and specialty drugs, it plays a key role in providing affordable medications. Investors monitor its performance due to its significant presence in the generic drug market and its ability to navigate regulatory challenges.
Market Cap: $3.7B52W Range: $6.68 – $15.42
Congressional Interest in Amneal Pharmaceuticals, Inc. (AMRX)
3 members of Congress have disclosed 3 trades in Amneal Pharmaceuticals, Inc. (AMRX), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
3
Unique Politicians
3
Buys
1
Sells
2
Who in Congress Is Trading AMRX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-09-09 | Rohit Khanna | sell | $1K – $15K |
| 2019-05-29 | Gilbert Cisneros | sell | $1K – $15K |
| 2019-05-24 | Josh Gottheimer | buy | $1K – $15K |